Publications by authors named "Imran Chaudhary"

Claim this Profile
A
A phase I safety and efficacy clinical trial of plocabulin and gemcitabine in patients with advanced solid tumors.
Mohammad H Ghalib, Mariano Provencio Pulla, Maria J De Miguel Luken, Virginia Calvo de Juan, Imran Chaudhary

Invest New Drugs· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes Among Racial and Ethnic Minority Patients With Advanced Cancers in Phase 1 Trials: A Meta-Analysis.
Sanjay Goel, Abdissa Negassa, Mohammad H Ghalib, Imran Chaudhary, Kavita Desai

JAMA Netw Open· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncolytic Reovirus (pelareorep) Induces Autophagy in KRAS-mutated Colorectal Cancer.
Jeeshan Jiffry, Thongthai Thavornwatanayong, Devika Rao, Elisha J Fogel, Durvanand Saytoo, Imran Chaudhary

Clin Cancer Res· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elucidation of Pelareorep Pharmacodynamics in A Phase I Trial in Patients with -Mutated Colorectal Cancer.
Sanjay Goel, Allyson J Ocean, Ruwan Y Parakrama, Mohammad H Ghalib, Imran Chaudhary

Mol Cancer Ther· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Excision repair cross-complementing group-1 (ERCC1) induction kinetics and polymorphism are markers of inferior outcome in patients with colorectal cancer treated with oxaliplatin.
Devika Rao, Atrayee Basu Mallick, Titto Augustine, Cecilia Daroqui, Jeeshan Jiffry, Imran Chaudhary

Oncotarget· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival outcome and prognostic model of patients with colorectal cancer on phase 1 trials.
Audrey E Kam, Gopichand Pendurti, Umang H Shah, Mohammad H Ghalib, Imran Chaudhary

Invest New Drugs· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Effectiveness Research: The Impact of Biologic Agents in Ethnic Minorities With Metastatic Colorectal Cancer.
Sanjay Goel, Abdissa Negassa, Ashish Khot, Dharmendra Goyal, Shuang Guo, Imran Chaudhary

Clin Colorectal Cancer· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcome and prognostic markers for patients with gynecologic malignancies in phase 1 clinical trials: a single institution experience from 1999 to 2010.
June Y Hou, Santiago Aparo, Mohammad Ghalib, Imran Chaudhary, Umang Shah

Gynecol Oncol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, pharmacokinetics, and activity of EZN-2208, a novel conjugate of polyethylene glycol and SN38, in patients with advanced malignancies.
Razelle Kurzrock, Sanjay Goel, Jennifer Wheler, David Hong, Siqing Fu, Imran Chaudhary

Cancer· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eribulin -- a review of preclinical and clinical studies.
Umang Swami, Imran Chaudhary, Mohammad H Ghalib, Sanjay Goel

Crit Rev Oncol Hematol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravenous administration of Reolysin, a live replication competent RNA virus is safe in patients with advanced solid tumors.
Radharani Gollamudi, Mohammad H Ghalib, Kavita K Desai, Imran Chaudhary, Benny Wong

Invest New Drugs· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alterations of chemotherapeutic pharmacokinetic profiles by drug-drug interactions.
Sridhar Mani, Mohammed Ghalib, Imran Chaudhary, Sanjay Goel

Expert Opin Drug Metab Toxicol· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic and safety study of weekly irinotecan and oral capecitabine in patients with advanced solid cancers.
Sanjay Goel, Kavita Desai, Sirisha Karri, Radharani Gollamudi, Imran Chaudhary

Invest New Drugs· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis